Join for Free!
122076 members

table of contents table of contents

Epidemiological evidence suggests a possible association between chronic exposures to toxigenic molds …

Home » Biology Articles » Toxicology » High Cholesterol Levels And Chronic Exposure To Toxigenic Molds In Damp Buildings: A High Risk For Cardiovascular Diseases And Stroke » References

- High Cholesterol Levels And Chronic Exposure To Toxigenic Molds In Damp Buildings: A High Risk For Cardiovascular Diseases And Stroke

1. Anyanwu EC, Campbell AW, Ehiri J. Mycotoxins and antifungal drugs interactions: implications in the treatment of illnesses due to indoor chronic toxigenic mold exposures. TheScientificWorldJOURNAL, 2004; 4: 167-177

2. Anyanwu E, Campbell AW, Vojdani A, Ehiri JE, Akpan IA. Biochemical changes in the serum of patients with chronic toxigenic mold exposures: a risk factor for multiple renal dysfunctions. ScientificWorldJournal. 2003 Nov 3;3(11):1058-64.

3. Anyanwu EC, Campbell AW, Jones J, Ehiri J. The neurological significance of abnormal natural killer cell activity in chronic toxigenic mold exposures. TheScientificWorldJOURNAL (2003), 3, 1128-1137

4. John Henkel J. FDA Consumer magazine, January-February 1999

5. Menetrez MY, Foarde KK, Ensor DS. An analytical method for the measurement of nonviable bioaerosols. J Air Waste Manag Assoc 2001 Oct;51(10):1436-42

6. Robbins CA, Swenson LJ, Nealley ML, Gots RE, Kelman BJ. Health effects of mycotoxins in indoor air: a critical review. Appl Occup Environ Hyg 2000 Oct;15(10):773-84

7. Kaplan LA, Pesce AJ. Clinical Chemistry, Theory, analysis, and correlation, 2nd ed. Philadelphia 1989, The CV Mosby Company.

8. Croft JB, Cresanta JL, Webber LS, Srinivasan SR, Freedman DS, Burke GL, Berenson GS. Cardiovascular risk in parents of children with extreme lipoprotein cholesterol levels: the Bogalusa Heart Study. South Med J 1988 Mar;81(3):341-9, 353

9. Darnell J, Lodish H, Baltimore D. Molecular Cell Biology 2nd ed. New York, 1990, WH. Freeman and Company.

10. Cholesterol: Structure and Function in the Human Body holesterol Prerequisites: Particulate Nature of Matter (atoms and molecules) Atomic Structure and Periodic Properties (orbitals, electron configurations) Structure and Bonding (covalent bonding, [mc2.cchem.berkeley.edu/modules/c ... ] )

11. King MW. Indiana University School of Medicine. E-mail: [email protected]

12. Deng X, King MW, Guidoin R. Localization of atherosclerosis in arterial junctions. Concentration distribution of low density lipoproteins at the luminal surface in regions of disturbed flow. ASAIO J 1995 Jan-Mar;41(1):58-67

13. Jin W, Marchadier D, Rader DJ. Lipases and HDL metabolism. Trends Endocrinol Metab 2002 May;13(5):174-8

14. Park Y, Pariza MW. Lipoxygenase inhibitors inhibit heparin-releasable lipoprotein lipase activity in 3T3-L1 adipocytes and enhance body fat reduction in mice by conjugated linoleic acid. Biochim Biophys Acta 2001 Nov 30;1534(1):27-33

15. Barrett PH, Watts GF. Shifting the LDL-receptor paradigm in familial hypercholesterolemia: novel insights from recent kinetic studies of apolipoprotein B-100 metabolism. Atheroscler Suppl 2002 Mar;2(3):1-4

16. Bousquet-Dubouch MP, Graber M, Sousa N, Lamare S, Legoy MD. Alcoholysis catalyzed by Candida antarctica lipase B in a gas/solid system obeys a Ping Pong Bi Bi mechanism with competitive inhibition by the alcohol substrate and water. : Biochim Biophys Acta 2001 Nov 26;1550(1):90-9

17. Sedlakova A, Kohut A, Sarissky M. Changes of gastric lipase activity after ethanol and indomethacin administration: influence of pretreatment with allopurinol, pentoxifylline and L-DOPA. Physiol Res 2001;50(3):299-307

18. Chiou A, Verger R, Kokotos G. Synthetic routes and lipase-inhibiting activity of long-chain alpha-keto amides. Lipids 2001 May;36(5):535-42

19. Ruiz B, Farres A, Langley E, Masso F, Sanchez S. Purification and characterization of an extracellular lipase from Penicillium candidum. Lipids 2001 Mar;36(3):283-9

20. Rassoul F, Richter V, Lohse P, Naumann A, Purschwitz K, Keller E. Long-term administration of the HMG-CoA reductase inhibitor lovastatin in two patients with cholesteryl ester storage disease. Int J Clin Pharmacol Ther 2001 May;39(5):199-204

21. Ohanian J, Ohanian V. Sphingolipids in mammalian cell signalling. Cell Mol Life Sci 2001 Dec;58(14):2053-68

22. Eichner JE, Dunn ST, Perveen G, Thompson DM, Stewart KE, Stroehla BC. Apolipoprotein E polymorphism and cardiovascular disease: a HuGE review. Am J Epidemiol 2002 Mar 15;155(6):487-95

23. Laber U, Kober T, Schmitz V, Schrammel A, Meyer W, Mayer B, Weber M, Kojda G. Effect of hypercholesterolemia on expression and function of vascular soluble guanylyl cyclase. Circulation 2002 Feb 19;105(7):855-60

24. Csont T, Balogh G, Csonka C, Boros I, Horvath I, Vigh L, Ferdinandy P. Hyperlipidemia induced by high cholesterol diet inhibits heat shock response in rat hearts. Biochem Biophys Res Commun 2002 Feb 8;290(5):1535-8

25. Wiesbauer F, Kaun C, Zorn G, Maurer G, Huber K, Wojta J. HMG CoA reductase inhibitors affect the fibrinolytic system of human vascular cells in vitro: a comparative study using different statins. Br J Pharmacol 2002 Jan;135(1):284-92

26. Rahman K, Coleman R. Selective biliary lipid secretion at low bile-salt-output rates in the isolated perfused rat liver. Effects of phalloidin. Biochem J 1986 Jul 1;237(1):301-4

27. Furuta I, Obana Y, Yamazumi T, Ohba Y, Kimura M, Suzuki T, Hashimoto S. Retrospective analysis of deep-seated candidiasis among cases autopsied between 1982 to 1991. Kansenshogaku Zasshi 1994 Jul;68(7):879-86

28. Bobek P, Ginter E, Jurcovicova M, Ozdin L, Mekinova D. Effect of oyster fungus (Pleurotus ostreatus) on serum and liver lipids of Syrian hamsters with a chronic alcohol intake. Physiol Res 1991;40(3):327-32

29. Casado JM, Theumer M, Masih DT, Chulze S, Rubinstein HR. Experimental subchronic mycotoxicoses in mice: individual and combined effects of dietary exposure to fumonisins and aflatoxin B1. Food Chem Toxicol 2001 Jun;39(6):579-86

30. Slyper AH. Childhood obesity, adipose tissue distribution, and the pediatric practitioner. Pediatrics 1998 Jul;102(1):e4

31. Akisu M, Darcan S, Oral R, Kultursay N. Serum lipid and lipoprotein composition in infants of diabetic mothers. Indian J Pediatr 1999 May-Jun;66(3):381-6

32. Rabelo LM, Viana RM, Schimith MA, Patin RV, Valverde MA, Denadai RC, Cleary AP, Lemes S, Auriemo C, Fisberg M, Martinez TL. Risk factors for atherosclerosis in students of a private university in Sao Paulo-Brazil. Arq Bras Cardiol 1999 May;72(5):569-80

33. Rabe-Jablonska J, Poprawska I. Levels of serum total cholesterol and LDL-cholesterol in patients with major depression in acute period and remission. Med Sci Monit. 2000 May-Jun;6(3):539-47.

34. Kwiterovich PO Jr. Detection and treatment of elevated blood lipids and other risk factors for coronary artery disease in youth. Ann N Y Acad Sci 1995 Jan 17;748:313-30; discussion 331-2

35. Stragliotto E, Camera M, Postiglione A, Sirtori M, Di Minno G, Tremoli E. Functionally abnormal monocytes in hypercholesterolemia. Artherioscler Thromb 1993 Jun;13(6):944-50.

rating: 0.00 from 0 votes | updated on: 30 Apr 2008 | views: 9853 |

Rate article: